Polar Asset Management Partners’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-366,000
Closed -$95K 868
2020
Q3
$95K Hold
366,000
﹤0.01% 563
2020
Q2
$165K Hold
366,000
﹤0.01% 450
2020
Q1
$24K Sell
366,000
-8,600
-2% -$1.04K ﹤0.01% 413
2019
Q4
$65K Hold
374,600
﹤0.01% 396
2019
Q3
$64K Hold
374,600
﹤0.01% 399
2019
Q2
$82K Buy
374,600
+174,600
+87% +$30.9K ﹤0.01% 358
2019
Q1
$36K Hold
200,000
﹤0.01% 337
2018
Q4
$77K Hold
200,000
﹤0.01% 328
2018
Q3
$83K Hold
200,000
﹤0.01% 334
2018
Q2
$76K Hold
200,000
﹤0.01% 368
2018
Q1
$74K Hold
200,000
﹤0.01% 325
2017
Q4
$93K Buy
+200,000
New +$76.2K ﹤0.01% 351

Other funds holding NRXPW

Polar Asset Management Partners's NRXPW Position: Q4 2020 in Review

Polar Asset Management Partners sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q4 2020, closing a stake of 366,000 shares — an estimated $95K sold.

Polar Asset Management Partners first reported a position in NRXPW in Q4 2017 and held it in 12 quarters. The position peaked at $165K in Q2 2020. 2 funds tracked by Wall St. Rank hold NRXPW as of Q4 2020.

  • Polar Asset Management Partners reported no remaining NRX Pharmaceuticals Warrant position as of Q4 2020 after selling out during the quarter.
  • Polar Asset Management Partners sold 366,000 NRX Pharmaceuticals Warrant shares in Q4 2020, an estimated $95K.
  • Polar Asset Management Partners first reported a position in NRX Pharmaceuticals Warrant in Q4 2017 and held it in 12 quarters.
  • Polar Asset Management Partners's NRX Pharmaceuticals Warrant position peaked at $165K in Q2 2020.
  • 2 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q4 2020.

Based on Polar Asset Management Partners's 13F filing for Q4 2020, filed 16 Feb 2021.